WBH ADVISORY INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
WBH ADVISORY INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$212,000
-10.9%
1,9110.0%0.03%
-17.1%
Q4 2020$238,000
-3.6%
1,911
-11.2%
0.04%
-19.6%
Q4 2019$247,000
-11.5%
2,152
-2.7%
0.05%
-19.0%
Q3 2019$279,000
+3.3%
2,212
-1.7%
0.06%0.0%
Q2 2019$270,000
+14.4%
2,250
-4.7%
0.06%
+10.5%
Q4 2018$236,000
-12.6%
2,3600.0%0.06%
-12.3%
Q3 2018$270,000
+20.5%
2,360
-5.6%
0.06%
+12.1%
Q2 2018$224,0002,5000.06%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders